Ken Fisher
TAK icon

Ken Fisher’s Takeda Pharmaceutical TAK Stock Holding History

Ken Fisher’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,484
Closed -$593K – 1098
2025
Q3 		$593K Sell
40,484
-58,151
-59% -$864K ﹤0.01% 754
2025
Q2 		$1.52M Buy
98,635
+46,490
+89% +$687K ﹤0.01% 619
2025
Q1 		$775K Buy
52,145
+10,811
+26% +$151K ﹤0.01% 724
2024
Q4 		$547K Buy
+41,334
New +$568K ﹤0.01% 764
2021
Q4 		– Sell
-10,339
Closed -$169K – 998
2021
Q3 		$169K Buy
+10,339
New +$174K ﹤0.01% 887

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ken Fisher's TAK Position: Q4 2025 in Review

Ken Fisher sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 40,484 shares — an estimated $593K sold.

Ken Fisher first reported a position in TAK in Q3 2021 and held it in 5 quarters. The position peaked at $1.52M in Q2 2025. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • Ken Fisher reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Ken Fisher sold 40,484 Takeda Pharmaceutical shares in Q4 2025, an estimated $593K.
  • Ken Fisher first reported a position in Takeda Pharmaceutical in Q3 2021 and held it in 5 quarters.
  • Ken Fisher's Takeda Pharmaceutical position peaked at $1.52M in Q2 2025.
  • 349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.